← The Wire
ELANNYSE
Elanco Animal Health Inc
Pharmaceutical Preparations · CIK 1739104
Elanco Animal Health Inc develops and markets products for the prevention and treatment of disease in food and companion animals
$12.07B
Market cap
$24.74
Last close
+0.7%
1D
+3.5%
5D
3.3M
Volume
Price · last 39 sessions+9.9%
May 4L $19.80 · H $26.18Jun 29
203
Total filings
May 27, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 27, 202610-Q10-Q FOR THE PERIOD ENDED MARCH 31, 2026May 6, 20268-KResults of OperationsMay 6, 2026DEFA14ADEFA14AApr 8, 2026DEF 14ADEF 14AApr 8, 202610-K10-K FOR THE YEAR ENDED DECEMBER 31, 2025Feb 24, 20268-KResults of OperationsFeb 24, 20268-KReg FD DisclosureJan 12, 20268-KExit / Disposal Costs · Reg FD DisclosureDec 9, 202510-Q10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2025Nov 5, 20258-KResults of OperationsNov 5, 20258-KMaterial Agreement · New Debt / ObligationNov 3, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KMaterial Agreement · New Debt / ObligationJun 26, 20258-KExecutive Change · Reg FD DisclosureMay 28, 20258-KShareholder VoteMay 21, 202510-Q10-Q FOR THE PERIOD ENDED MARCH 31, 2025May 7, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AMar 27, 2025DEF 14ADEF 14AMar 27, 20258-KExecutive Change · Reg FD DisclosureMar 17, 202510-K10-K FOR THE YEAR ENDED DECEMBER 31, 2024Feb 25, 20258-KResults of OperationsFeb 25, 20258-KReg FD DisclosureJan 13, 20258-KExecutive Change · Reg FD DisclosureNov 12, 202410-Q10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2024Nov 7, 20248-KResults of OperationsNov 7, 20248-KReg FD DisclosureOct 16, 20248-KMaterial Agreement · New Debt / ObligationAug 13, 202410-Q10-Q FOR THE PERIOD ENDED JUNE 30, 2024Aug 8, 20248-KResults of OperationsAug 8, 20248-KAcquisition / Disposition · Reg FD DisclosureJul 9, 20248-KMaterial Agreement · New Debt / ObligationJul 3, 20248-KExecutive Change · Bylaw AmendmentJun 4, 202410-Q10-Q FOR THE PERIOD ENDED MARCH 31, 2024May 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 19, 2024DEF 14ADEF 14AApr 19, 20248-KExecutive Change · Material AgreementApr 1, 2024DEFA14ADEFA14AFeb 29, 2024DEFA14ADEFA14AFeb 29, 202410-K10-K FOR THE YEAR ENDED DECEMBER 31, 2023Feb 26, 20248-KResults of Operations · Exit / Disposal CostsFeb 26, 20248-KMaterial Agreement · Reg FD DisclosureFeb 5, 2024SC 13GSC 13GJan 29, 20248-KReg FD DisclosureJan 8, 20248-KReg FD DisclosureJan 2, 202410-Q10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2023Nov 7, 20238-KResults of OperationsNov 7, 20238-KReg FD DisclosureOct 4, 202310-Q10-Q FOR THE PERIOD ENDED JUNE 30, 2023Aug 7, 20238-KMaterial Agreement · Results of OperationsAug 7, 20238-KReg FD Disclosure · Company UpdateJul 13, 20238-KCompany UpdateJul 10, 20238-KExecutive Change · Shareholder VoteMay 22, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 2023DEFA14ADEFA14AApr 6, 2023DEF 14ADEF 14AApr 6, 202310-K10-KMar 1, 20238-K/AResults of OperationsMar 1, 20238-KResults of OperationsFeb 21, 20238-KCompany UpdateJan 31, 20238-KReg FD DisclosureJan 9, 202310-Q10-QNov 8, 20228-KResults of OperationsNov 8, 20228-KExecutive Change · Company UpdateSep 8, 202210-Q10-QAug 8, 20228-KResults of OperationsAug 8, 2022SC 13GSC 13GJul 8, 20228-KMaterial Agreement · New Debt / ObligationJun 29, 20228-KExecutive Change · Bylaw AmendmentMay 19, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 20228-KMaterial Agreement · New Debt / ObligationApr 20, 20228-KExecutive Change · Reg FD DisclosureApr 13, 2022DEFA14ADEFA14AApr 6, 2022DEF 14ADEF 14AApr 6, 20228-KReg FD DisclosureMar 29, 2022
Insider Activity
◆ Cluster Buy · 4 insidersIn the 90 days to Dec 12, 2025: 4 insiders bought $938K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Kurzius Lawrence ErikDirector | Buy | 10,000 | $21.30 | $213K |
| Dec 11, 2025 | Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR | Buy | 22,000 | $21.75 | $479K |
| Dec 11, 2025 | Vanhimbergen Robert MEVP and CFO | Buy | 6,950 | $21.64 | $150K |
| Dec 11, 2025 | Modi Rajeev A.SEE REMARKS | Buy | 4,500 | $21.33 | $96K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Coverage (30d): 2 reputable articles · skews ▲ positive.
Morningstar9 New 4-Star Stocks This Week14d agoCNBCConfirmed screwworm case in Texas sends two biotech stocks higher26d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance